Category: HealthSubscribe via RSS Feed

Covid-flu joint booster jab possible late 2023: Moderna

19-Jan-2022 Intellasia | AFP | 5:02 AM

Moderna aims to roll out a combined Covid-flu-RSV booster vaccine in late 2023, the US pharmaceutical firm said Monday, hoping a joint jab would encourage people to get an [...] » More

J&J booster 85pct effective against Omicron hospitalisation, S.Africa says

15-Jan-2022 Intellasia | Reuters | 5:02 AM

A Johnson and Johnson COVID-19 vaccine booster shot is 85 percent effective in protecting against being hospitalised by the Omicron variant for 1-2 months after it is [...] » More

WHO warns against treating Covid 19 like flu

13-Jan-2022 Intellasia | Reuters | 7:05 AM

The World Health Organization (WHO) on Tuesday warned against treating COVID-19 as an endemic illness like flu, rather than as a pandemic, saying the spread of the Omicron [...] » More

Half of Europe on track to catch Omicron as China locks down millions

13-Jan-2022 Intellasia | AFP | 7:05 AM

More than half of people in Europe are projected to catch Omicron in the next two months, the WHO said Tuesday, as millions in China faced fresh lockdowns on the two-year [...] » More

Pandemic may affect infants’ brain development; coronavirus can trigger kidney scarring

08-Jan-2022 Intellasia | Reuters | 5:02 AM

The following is a summary of some recent studies on COVID-19. They include research that warrants further study to corroborate the findings and that has yet to be certified [...] » More

Calling Omicron ‘mild’ a mistake, says WHO

08-Jan-2022 Intellasia | AFP | 5:02 AM

The Omicron variant of Covid-19 is killing people across the globe and should not be dismissed as mild, the World Health Organization warned on Thursday. WHO chief Tedros [...] » More

CDC advisory panel in favour of Pfiser vaccine booster for ages 12 to 15

06-Jan-2022 Intellasia | Reuters | 4:31 PM

A panel of outside experts advising the US Centers for Disease Control and Prevention (CDC) on Wednesday voted to recommend booster shots of Pfiser Inc (PFE.N) and BioNTech [...] » More

India says safety concerns restricting use of Merck COVID pill

India says safety concerns restricting use of Merck COVID pill

06-Jan-2022 Intellasia | Reuters | 4:30 PM

India has not added Merck’s (MRK.N) COVID-19 pill to its national treatment protocol for the disease due to known safety concerns that have restricted its use [...] » More

Soaring Omicron could lead to more dangerous variants, WHO warns

05-Jan-2022 Intellasia | AFP | 12:24 PM

Soaring Omicron cases around the globe could increase the risk of a newer, more dangerous variant emerging, the World Health Organisation in Europe warned yesterday. While [...] » More

J&J booster slashes Omicron hospitalisations S.African study

J&J booster slashes Omicron hospitalisations S.African study

01-Jan-2022 Intellasia | Reuters | 5:02 AM

A booster dose of Johnson & Johnson Inc’s (JNJ.N) single-dose COVID-19 vaccine was 84 percent effective at preventing hospitalisation in South African healthcare [...] » More

Scientists identify antibodies that can neutralise Omicron and other variants

31-Dec-2021 Intellasia | The Independent | 5:02 AM

Scientists have identified antibodies that can target the unchanged parts of the novel coronavirus as it continues to mutate and evolve, an advance that could lead to new [...] » More

UAE approves Sinopharm’s protein-based vaccine

29-Dec-2021 Intellasia | Reuters | 7:04 AM

The United Arab Emirates has approved emergency use of Sinopharm’s protein-based COVID-19 vaccine and it will be available to the public as a booster dose starting [...] » More

No country can boost its way out of pandemic: WHO chief

24-Dec-2021 Intellasia | AFP | 5:02 AM

The World Health Organization chief warned Wednesday that the rush in wealthy countries to roll out additional Covid vaccine doses was deepening the inequity in access to [...] » More

EU set to back Novavax Covid vaccine

24-Dec-2021 Intellasia | AFP | 5:02 AM

The EU’s drug regulator will decide Monday whether to approve a Covid jab by Novavax, which uses a more conventional technology that the US biotech firm hopes will [...] » More

Data hunters will be Big Pharma’s next prey

22-Dec-2021 Intellasia | Reuters | 5:02 AM

Big Pharma will need to tool up in the data arms race. Drug giants like AstraZeneca (AZN.L) are pouring $160 billion a year into unearthing new treatments. Artificial [...] » More